Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating Glinib in newly diagnosed chronic myeloid leukemia patients has been terminated. The trial aimed to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Glinib

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Chronic Myeloid Leukemia | Phase 4 | Status: TERMINATED